Video

Dr. Ross Discusses the Future Treatment Landscape of Melanoma

Author(s):

Merrick I. Ross, MD

Merrick I. Ross, MD, professor, Department of Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, discusses the future treatment landscape of melanoma.

Merrick I. Ross, MD, professor, Department of Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, discusses the future treatment landscape of melanoma.

The landscape of melanoma moving forward is multi-faceted, says Ross, particularly with neoadjuvant therapies.

Related Videos
Ashkan Emadi, MD, PhD
Alexis LeVee, MD
Martin Dreyling, MD
Tom van Meerten, MD, PhD, hematologist, Department of Hematology, University Medical Center Groningen
John H. Strickler, MD
Junjie Li, MD
Peter Riedell, MD
Jorge Cortes, MD
Michael R. Bishop, MD
Lori A Leslie, MD
Related Content
This week’s top 5 includes a snapshot of FDA approvals from December, an exclusive roundup of critical NCCN guideline updates from 2024, and more.
January 4th 2025

The OncFive: Top Oncology Articles for the Week of 12/29

OncLive On Air
September 11th 2024

Oncology Experts Preview Top Abstracts From the 2024 ESMO Congress

Lynn M. Schuchter, MD
January 1st 2025

A 30-Year Commitment to Advancing Melanoma Care

Jeffrey S. Weber, MD, PhD
November 6th 2023

FDA Approval Insights: Adjuvant Nivolumab in Completely Resected Stage IIB/C Melanoma

OncLive’s December Roundup of Key FDA Approvals in Oncology
December 30th 2024

OncLive’s December Roundup of Key FDA Approvals in Oncology

Omid Hamid, MD
December 25th 2024

Novel Therapies and Combinations Augment Melanoma Treatment Arsenal